Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome.
Tsuruga
Kazushi
K
Oki
Eishin
E
Yashiro
Tomomi
T
Ito
Etsuro
E
Tanaka
Hiroshi
H
D000418:Albumins / Q000235:genetics / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D009404:Nephrotic Syndrome / Q000097:blood*; D010865:Pilot Projects; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
D000418:Albumins; D004232:Diuretics; D011994:Recombinant Proteins; D005665:Furosemide